Pharma Journalist -

Miraca Life Sciences continues to expand in clinical pathology: its InformTx™ therapeutic drug monitoring (TDM) has begun the validation process for Renflexis™ (infliximab-abda), a…
Read More...

Ionis Pharmaceuticals, Inc. announced that it has initiated a Phase 1/2a clinical study of IONIS-MAPTRx in patients with mild Alzheimer's disease (AD). Ionis earned a $10 million…
Read More...

TARGET PharmaSolutions announced that Bristol-Myers Squibb (BMY) has extended its strategic partnership for TARGET-NASH to a multi-year agreement.  Bristol-Myers Squibb is committed to…
Read More...

Flex Pharma announced that, under its open investigational new drug (IND) application, the Company has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial…
Read More...

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of the transaction is…
Read More...

Next January in San Francisco LEAP HR will host a 2 day forum for progressive HR leaders from the world of bio pharma to totally rethink the people strategies needed in this…
Read More...

AcelRx Pharmaceuticals announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for DSUVIA™ …
Read More...

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials to evaluate brexpiprazole for the treatment of patients with…
Read More...

Merz and Teijin Limited announced that they have entered into a strategic license and co-development agreement for the commercialization of Xeomin (incobotulinumtoxinA) for Japan.…
Read More...

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France. The expansion further strengthens Sanofi's position as one of the world's leading…
Read More...